Embed

Academic

Authors

Paul Wayne Armstrong

Paul Wayne Armstrong,University of Alberta,Cardiology,Pharmacology,Neuroscience

Edit

Paul Wayne Armstrong

University of Alberta

Publications: 484 | Citations: 7360

Fields: Cardiology, Pharmacology, Neuroscience

Collaborated with 977 co-authors from 1990 to 2012 | Cited by 17824 authors

Cumulative Annual

Sort by:

Publications (484)

BibTeX | RIS | RefWorks Download

Impact of TIMI 3 patency before primary percutaneous coronary intervention for ST-elevation myocardial infarction on clinical outcome: results from the ASSENT4 PCI study

, , , , , , ,

Published in 2012.

Temporal trends in patient and treatment delay among men and women presenting with ST-elevation myocardial infarction (Citations: 2)

, , , , ,

Journal: American Heart Journal - AMER HEART J , vol. 161, no. 1, pp. 91-97, 2011

The influence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction: A pooled analysis of an early fibrinolytic strategy versus primary percutaneous coronary intervention from CAPTIM and WEST (Citations: 1)

, , , , ,

Journal: American Heart Journal - AMER HEART J , vol. 161, no. 2, pp. 283-290, 2011

Clinical Outcomes at 180 days in the ASCEND-HF Trial: Double-Blind, Placebo-Controlled, Multicenter Acute Study of Clinical Effectiveness of Nesiritide in Subjects With Decompensated Heart Failure

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=49522749&selfId1=21104173&selfId2=0&maxNumber=12&query=

Journal: Journal of Cardiac Failure - J CARD FAIL , vol. 17, no. 11, pp. 971-971, 2011

ASSOCIATION OF HUB AND SPOKE PRACTICE PATTERNS WITH CORONARY INTERVENTION AND OUTCOMES IN NON ST ELEVATION ACUTE CORONARY SYNDROMES (NSTE ACS): INSIGHTS FROM THE EARLY GLYCOPROTEIN IIB/IIIA INHIBITION IN NSTE ACS (EARLY-ACS) TRIAL

, , , , , , , , , , ,

Journal: Journal of The American College of Cardiology - J AMER COLL CARDIOL , vol. 57, no. 14, pp. E1101-E1101, 2011

Sort by:

Citations (7360 times by 5708 publications)

Clinical Trial Educator program – a novel approach to accelerate enrollment in a phase III International Acute Coronary Syndrome Trial

, , , , , , , ,

Journal: Clinical Trials - CLIN TRIALS , vol. 9, no. 3, pp. 358-366, 2012

Relationship Between Exposure to Prasugrel Active Metabolite and Clinical Outcomes in the TRITON-TIMI 38 Substudy

, , , , , , , , , ,

Journal: Journal of Clinical Pharmacology - J CLIN PHARMACOL , vol. 52, no. 6, pp. 789-797, 2012

Shift From Surrogate End Point to Outcome Trials: Implications for Cardiovascular Safety Assessment in Development Programs for Antidiabetic Drugs

, , , , ,

Journal: Clinical Pharmacology & Therapeutics - CLIN PHARMACOL THER , vol. 91, no. 3, pp. 514-520, 2012

Crossover Dose Escalation Study to Assess Safety, Pharmacokinetics, and Pharmacodynamics of Single Doses of R1663, an Oral Factor Xa Inhibitor, in Healthy Male Volunteers

, , , , , ,

Journal: Journal of Clinical Pharmacology - J CLIN PHARMACOL , vol. 52, no. 4, pp. 499-510, 2012

Prognostic Significance of Prevalent and Incident Atrial Fibrillation Among Patients Hospitalized with Acute Coronary Syndrome: Findings from the Gulf RACE2 Registry

, , , , , , , , , , ,

Journal: Angiology , vol. 63, no. 6, pp. 466-471, 2012

Comments

Co-authors (977)

Journals (56)

Keywords (463)

Paul Wayne Armstrong,University of Alberta,Cardiology,Pharmacology,Neuroscience

Publications (484)

BibTeX | RIS | RefWorks Download

Impact of TIMI 3 patency before primary percutaneous coronary intervention for ST-elevation myocardial infarction on clinical outcome: results from the ASSENT4 PCI study

Temporal trends in patient and treatment delay among men and women presenting with ST-elevation myocardial infarction (Citations: 2)

The influence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction: A pooled analysis of an early fibrinolytic strategy versus primary percutaneous coronary intervention from CAPTIM and WEST (Citations: 1)

Clinical Outcomes at 180 days in the ASCEND-HF Trial: Double-Blind, Placebo-Controlled, Multicenter Acute Study of Clinical Effectiveness of Nesiritide in Subjects With Decompensated Heart Failure

ASSOCIATION OF HUB AND SPOKE PRACTICE PATTERNS WITH CORONARY INTERVENTION AND OUTCOMES IN NON ST ELEVATION ACUTE CORONARY SYNDROMES (NSTE ACS): INSIGHTS FROM THE EARLY GLYCOPROTEIN IIB/IIIA INHIBITION IN NSTE ACS (EARLY-ACS) TRIAL

Citations (7360 times by 5708 publications)

Clinical Trial Educator program – a novel approach to accelerate enrollment in a phase III International Acute Coronary Syndrome Trial

Relationship Between Exposure to Prasugrel Active Metabolite and Clinical Outcomes in the TRITON-TIMI 38 Substudy

Shift From Surrogate End Point to Outcome Trials: Implications for Cardiovascular Safety Assessment in Development Programs for Antidiabetic Drugs

Crossover Dose Escalation Study to Assess Safety, Pharmacokinetics, and Pharmacodynamics of Single Doses of R1663, an Oral Factor Xa Inhibitor, in Healthy Male Volunteers

Prognostic Significance of Prevalent and Incident Atrial Fibrillation Among Patients Hospitalized with Acute Coronary Syndrome: Findings from the Gulf RACE2 Registry


	View FAQ about top research areas and Fields of study

Paul Wayne Armstrong,University of Alberta,Cardiology,Pharmacology,Neuroscience

Publications (484) BibTeX | RIS | RefWorks Download

Temporal trends in patient and treatment delay among men and women presenting with ST-elevation myocardial infarction (Citations: 2)

The influence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction: A pooled analysis of an early fibrinolytic strategy versus primary percutaneous coronary intervention from CAPTIM and WEST (Citations: 1)

Publications (484)

BibTeX | RIS | RefWorks Download